Surgically implanted lens company Presbia files for a $90 million IPO

By
A A A

Presbia, which sells a surgically implanted lens to correct age-related vision loss, filed on Thursday with the SEC to raise up to $90 million in an initial public offering. It targets the common vision disorder presbyopia, which affects 1.8 billion people worldwide. The Irvine, CA-based company, which was founded in 2007, plans to list on the NASDAQ under the symbol LENS. Jefferies is the sole bookrunner on the deal. No pricing terms were disclosed.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

260,715,402
    $93.19 unch
216,795,225
  • $40.883 ▼ 2.86%
81,761,478
  • $5.36 ▼ 0.92%
75,343,119
  • $17.01 ▼ 0.18%
60,138,672
  • $47.46 ▲ 1.67%
60,089,422
  • $39.90 ▼ 3.97%
52,070,658
  • $101.54 ▼ 0.25%
48,699,408
  • $3.58 ▼ 1.51%
As of 9/19/2014, 03:52 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com